TAGRISSO (OSIMERTINIB MESYLATE)


TAGRISSO (OSIMERTINIB MESYLATE)

  • EGFR t790M mutation-positive non-small cell lung cancer
  • NSCLC with EGFR exon 19 deletion mutation
  • NSCLC with EGFR exon 21 (l858r) substitution mutation